Clinical Research

Edwards Lifesciences Corporation has shared new one-year data on the safety and effectiveness of its Evoque transcatheter tricuspid valve replacement (TTVR) system among patients with tricuspid regurgitation (TR)

Edwards shares new one-year data on transcatheter tricuspid valve replacement

The new findings, presented at the PCR London Valves 2022 conference, focused on mortality and heart failure hospitalization rates. 

Thumbnail

Use of NSAIDs 'should be revisited' after study reveals they may worsen arthritis

The use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are seeking when it comes to joint pain, according to new findings to be presented at RSNA 2022. 

By visualizing metabolism, researchers hope to improve heart disease diagnosis

Hyperpolarized MRI may help identify metabolism problems—which can be an early signal of a heart condition—in real time.

Early catheter ablation superior to medication when treating ventricular tachycardia storm

VT storm is associated with a heightened risk of death or significant complications. Early catheter ablation, it seems, is the most effective treatment option for this potentially fatal condition. 

Thumbnail

FDG PET/CT spots COVID-induced pancreatitis

There are limited data to determine whether pancreatitis in COVID patients is the result of a stress response triggered by severe illness or by direct damage to the β-cell structure and function.

Bruce Haffty, MD, president of Radiological Society of North America (RSNA) Board of Directors, chair of radiation oncology, associate vice chancellor for cancer programs at Rutgers Cancer Institute of New Jersey and system director of radiation oncology at RWJBarnabas Health, discusses the president’s address "Diagnostic Imaging: Value From the Lens of the Patient," with Radiology Business. Haffty will present his opening session at RSNA 2022 at 4 p.m., Nov. 27, 2022, in the Arie Crown theater.  

VIDEO: RSNA President Bruce Haffty previews the big conference in Chicago

Haffty offered his perspective on the conference as a whole and previewed his presidential address, which is scheduled for early Sunday evening.

Interview with the late-breaking BEST-CLI trial principal investigators Alik Farber from Boston Medical Center, Matthew Menard from Brigham and Women's Hospital, and Ken Rosenfield at Mass General Hospital, at the 2022 American Heart Association (AHA) meeting. The trial looked at endovascular versus bypass surgery in patients with critical limb ischemia (CLI) to see which is better. #AHA22

VIDEO: Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial. 

First-of-its-kind, dedicated lung scanner to be revealed at RSNA

The scans can be completed in less than five seconds and require less radiation than a traditional chest x-ray.